✨
AI Summary
- China deal-making dominated discussions at the BIO convention.
- Pharmaceutical companies are targeting $2 trillion in sales, driven by new therapies.
- Key topics include Apogee's role with AbbVie, Sangamo's bankruptcy, and Weber's Takeda tenure.